tradmap

CDIO Cardio Diagnostics Holdings, Inc.

$1.83 -1.08%

Updated

Healthcare · In Vitro & In Vivo Diagnostic Substances

Cardio Diagnostics Holdings, Inc. (CDIO) is a healthcare company in the In Vitro & In Vivo Diagnostic Substances industry, with a market capitalization of $5 million. Shares last traded at $1.83, 81.4% below their 52-week high. Over the past year the stock is down 48.5%. Revenue declined 57.5% year over year.

Market Cap
$5M
Shares Out
3.0M
EPS (TTM)
$-6.61
P/E Ratio
P/S Ratio
374.80
P/B Ratio
0.73
Dividend / Share
Dividend Yield
52-Week High
$9.84
52-Week Low
$0.97
Volume
548
Avg Vol (3m)
2,337.619

Performance

1W
-2.14%
1M
+4.57%
3M
-13.88%
6M
-66.05%
YTD
-34.88%
1Y
-48.45%

Daily candles · volume · SMA(20)/SMA(50) · split-adjusted · Databento EQUS.MINI. CDIO split history →

Technicals

RSI (14)
47.63
SMA (50)
$1.84
SMA (200)
$2.31
Price vs SMA50
-0.78%
Price vs SMA200
-20.73%
ATR (14)
$0.12

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$0M
Net Income
$-6M
Gross Margin
Operating Margin
Net Margin
Return on Equity
-87.1%
Return on Assets
-81.6%
Current Ratio
17.15
Debt / Equity
0.07
Revenue Growth (YoY)
-57.5%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $-1.13 2026-08-07
Q1 2026 $-0.63 2026-05-15
FY 2025 $-3.71 2026-03-13
Q3 2025 $-2.91 2025-11-12
Q2 2026 $-1.94 2026-08-07
Q1 2026 $-0.97 2026-05-15

Full earnings history →

In Vitro & In Vivo Diagnostic Substances peers

CDIO vs 14 industry peers (In Vitro & In Vivo Diagnostic Substances), by market cap. Updated

P/S vs peers
374.80 / 4.24 med
+8750% premium
1–14 of 14
IDXXIdexx Laboratories$41.7B36.589.1625.0%-1.81%
LNTHLantheus Holdings, Inc.$6.6B23.944.2417.7%+0.17%
CLDXCelldex Therapeutics, Inc.$3.1B-10.282000.34-0.32%
NEOGNeogen Corp$2.5B-322.002.92-0.9%-1.36%
NTLAIntellia Therapeutics, Inc.$1.8B-4.44-0.63%
QDELQuidelortho Corp$955M-0.910.36-39.2%-0.11%
ACHVAchieve Life Sciences, Inc.$855M-7.49-2.18%
TKNOAlpha Teknova, Inc.$388M-23.128.87-38.4%-2.83%
MYGNMyriad Genetics Inc$309M-2.740.38-14.0%-0.31%
IMDXInsight Molecular Diagnostics Inc.$135M-2.7433.41+2.99%
ICCCIMMUCELL CORP /DE/$90M114.192.932.6%-0.35%
QCLSQ/C TECHNOLOGIES, INC.$15M-0.939.79-1.57%
BMRABIOMERICA INC$10M-2.732.31-84.8%+2.51%
CDIOCardio Diagnostics Holdings, Inc.$5M-0.84374.80-1.08%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.